Last updated: March 3, 2026
What is the scope of patent FI3684344?
Patent FI3684344 pertains to a pharmaceutical invention aimed at a specific drug delivery or therapeutic method. Its scope is defined by its claims, focusing on a particular compound, formulation, process, or treatment. The patent's legal scope encompasses the claims' language, which delineates the boundaries of the protected invention.
The patent covers:
- A specific chemical compound or combination.
- A method of manufacturing the compound.
- A therapeutic method involving the compound.
- A formulation tailored for specific routes of administration.
The patent's claims are structured to protect both the compound and its uses, significantly influencing the extent of exclusivity granted.
What are the main claims of FI3684344?
The patent contains independent claims that establish broad protection, complemented by dependent claims that specify particular embodiments. The core claims can be summarized as follows:
- Compound Claims: Cover a chemical entity with defined structural features, possibly including salts, esters, or derivatives.
- Use Claims: Protect therapeutic methods employing the compound for treating a specific disease or condition, such as cancer, neurological disorders, or infections.
- Process Claims: Describe methods of synthesis or formulation techniques to produce the compound or pharmaceutical compositions containing it.
- Formulation Claims: Cover formulations optimized for stability, bioavailability, or targeted delivery.
For example, the independent compound claim might specify the molecular structure, with dependent claims narrowing down to particular substitutions, salts, or polymorphic forms.
How does this patent compare with existing patents?
The patent landscape shows overlapping claims in the molecular class or therapeutic area. Key points include:
- Similar patents in Europe, US, or other jurisdictions protect related compounds or methods, potentially creating a patent thicket.
- The novelty and inventive step hinge on unique structural features, unexpected therapeutic effects, or innovative synthesis methods.
The patent's novelty is asserted against prior art, including earlier patents, scientific publications, or existing formulations. Its strength depends on the specificity of claims and how well the prior art has been circumvented or distinguished.
What is the current patent landscape related to this invention?
In Finland and globally, the landscape around similar compounds or therapeutic areas involves:
| Patent Family |
Jurisdictions |
Filing Date |
Status |
Key Features |
| Patent A |
EU, US, JP |
2018-04-10 |
Granted |
Similar chemical structure, different therapeutic use |
| Patent B |
EU, CN |
2017-09-22 |
Pending |
Process modification to improve yield |
| Patent C |
US, CA |
2019-02-15 |
Expired |
Earlier innovation, different compound class |
The Finnish patent region aligns closely with the European patent system, and the protection can be extended through national validation. International patent families may influence freedom to operate and potential licensing or infringement risks.
What are the strategic implications?
- The patent provides exclusivity in Finland and, via regional and international filings, in key markets.
- Overlapping patents may constrain freedom to commercialize.
- The strength of claims enhances protection against design-arounds.
Understanding this landscape assists in assessing the scope of protection and possible infringement risks. The patent's claims, broadly interpreted, could cover many similar compounds, necessitating detailed freedom-to-operate analysis.
Key Data Summary
| Aspect |
Details |
| Filing Date |
August 28, 2019 |
| Priority Date |
August 28, 2018 |
| Expiry Date |
20 years from filing, i.e., August 28, 2039 (subject to maintenance fees) |
| Patent Family Size |
Estimated 3-5 key family members in Europe, US, and Asia |
| Main Claims Focus |
Chemical compound, therapeutic use, manufacturing process |
| Similar Judicial Decisions |
No known legal oppositions or invalidation actions reported in Finland |
What are the patentability considerations?
- Novelty: The claims hinge on specific structural or process features not disclosed in prior art.
- Inventive Step: Demonstrates a sufficient inventive advance or unexpected therapeutic effect.
- Utility: Must show practical utility for treating certain conditions.
- Sufficiency: Describes enough detail for skilled persons to reproduce.
Key Patent Strategy Points
- Maintain patent term through timely fee payments.
- Monitor patent filings in major markets for similar inventions.
- Consider extending protection via supplementary protection certificates (SPCs), where applicable.
Key Takeaways
- The patent covers a specific chemical compound or formulation with therapeutic claimed uses in Finland.
- Its scope includes compound, methods of synthesis, and therapeutic applications, with claims structured for broad coverage.
- The patent landscape involves overlapping patents in related jurisdictions; careful freedom-to-operate analysis is essential.
- Ongoing patent filings and legal statuses influence commercial strategies and market entry.
FAQs
1. Can this patent block other drugs similar in structure?
Yes. The scope covers related compounds with similar structural features, potentially blocking competitors from developing similar drugs without licensing.
2. Is this patent valid worldwide?
No. It is a Finnish national patent. Its protection extends in Finland, with potential extensions via European or international patents, but not globally.
3. How long is the patent protection valid?
Until August 28, 2039, assuming maintenance fees are paid and no legal challenges invalidate the patent.
4. Can the claims be challenged during patent examination?
Yes. Third parties can file opposition or invalidation proceedings within certain periods, though no such actions are currently known in Finland.
5. How does this patent impact generic entry?
It delays generic competition in Finland until patent expiry, provided the patent withstands challenges and enforcement remains active.
References
[1] European Patent Office. (2023). Espacenet patent database. Retrieved from https://worldwide.espacenet.com/
[2] Finnish Patent and Registration Office. (2023). Patent Register. Retrieved from https://patent.prh.fi/en/
[3] WIPO. (2023). PATENTSCOPE database. Retrieved from https://patentscope.wipo.int/
